TMIGD2 Human

Transmembrane And Immunoglobulin Domain Containing 2 Human Recombinant
Cat. No.
BT25488
Source

HEK293 Cells.

Synonyms

IGPR-1, IGPR1,TMIGD2, Transmembrane and immunoglobulin domain-containing protein 2 isoform1, CD28 homolog, CD28H, Immunoglobulin and proline-rich receptor 1.

Appearance
Sterile Filtered colorless solution.
Purity

Greater than 95.0% as determined by SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

TMIGD2 Human Recombinant is a single, glycosylated, polypeptide chain (23-150 a.a) containing a total of 361 amino acids and having a molecular mass of 40.1 kDa.
TMIGD2 is fused to a 233 a.a hIgG -Tag at C-terminus and is purified by proprietary chromatographic techniques.

Product Specs

Description
TMIGD2 Human Recombinant is a single, glycosylated polypeptide chain (amino acids 23-150) containing 361 amino acids and having a molecular mass of 40.1 kDa. TMIGD2 is fused to a 233 amino acid hIgG-Tag at the C-terminus and is purified by proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered colorless solution.
Formulation
The TMIGD2 solution (1 mg/ml) contains 10% Glycerol and Phosphate-Buffered Saline (pH 7.4).
Stability
Store at 4 degrees Celsius if the entire vial will be used within 2-4 weeks. Store, frozen at -20 degrees Celsius for longer periods. For long-term storage, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid multiple freeze-thaw cycles.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Biological Activity
The ED50 range is less than or equal to 200 ng/ml and is measured by its binding ability in a functional ELISA with Human HHLA2.
Synonyms

IGPR-1, IGPR1,TMIGD2, Transmembrane and immunoglobulin domain-containing protein 2 isoform1, CD28 homolog, CD28H, Immunoglobulin and proline-rich receptor 1.

Source

HEK293 Cells.

Amino Acid Sequence

LSVQQGPNLL QVRQGSQATL VCQVDQATAW ERLRVKWTKD GAILCQPYIT NGSLSLGVCG PQGRLSWQAP SHLTLQLDPV SLNHSGAYVC WAAVEIPELE EAEGNITRLF VDPDDPTQNR NRIASFPGLE PKSCDKTHTC PPCPAPELLG GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRD ELTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR WQQGNVFSCS VMHEALHNHY TQKSLSLSPGK.

Product Science Overview

Structure and Localization

TMIGD2 is a transmembrane protein, meaning it spans the cell membrane and has both extracellular and intracellular domains . The extracellular domain contains immunoglobulin-like regions, which are important for its role in cell signaling and interactions . TMIGD2 is predominantly located in the plasma membrane and is also found in the extracellular space .

Function

TMIGD2 is involved in several key biological processes:

  • Cell-Cell Interaction: TMIGD2 enhances cell-cell interactions and aggregation, which is essential for maintaining tissue integrity and facilitating communication between cells .
  • Cell Migration: It plays a role in cell migration, a process critical for wound healing, immune responses, and development .
  • Angiogenesis: TMIGD2 positively regulates angiogenesis, the formation of new blood vessels from pre-existing ones, which is vital for tissue growth and repair .
Role in Immune Response

TMIGD2 is expressed on T cells and natural killer (NK) cells, where it acts as a co-receptor . It interacts with HHLA2, a member of the B7 family of immune regulatory proteins, to co-stimulate T cells and NK cells . This interaction enhances T cell proliferation and cytokine production through an AKT-dependent signaling cascade . As a result, TMIGD2 plays a significant role in modulating immune responses and maintaining immune homeostasis.

Clinical Significance

Given its role in immune regulation and angiogenesis, TMIGD2 is a potential therapeutic target for various diseases, including cancer and autoimmune disorders . Research is ongoing to explore its potential in immunotherapy and other therapeutic applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.